Both in Pharmaceuticals
Edgewise Therapeutics vs AbCellera Biologics
Over the past year EWTX returned +109.7% and ABCL returned +126.8%; their daily moves had a correlation of 0.23.
EWTX +109.7% ABCL +126.8%Growth of $1, one year, split-adjusted
| Metric | EWTX | ABCL |
|---|---|---|
| Price | $37.68 | $12.18 |
| Market cap | $4.09B | $3.95B |
| Today | −1.13% | +9.53% |
| 1 month | −6.5% | −11.6% |
| 6 months | −0.9% | +161.4% |
| Year to date | +51.8% | +256.1% |
| 1 year | +106.1% | +119.5% |
| Revenue growth (YoY) | — | −76.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −1368.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 59.6× |
| Net cash | $460.7M | $540.1M |
| Dividend yield | — | — |
| Volatility (60d) | 41.5% | 78.1% |
| Short % of float | 16.7% | 14.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).